Skip to main content
Equibles
SMMT logo

SMMT · Summit Therapeutics Inc. · Analyst Estimates

Track SMMT — free

Use SMMT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SMMT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.55 +0.55 (+3.24%) At close · Sep 11
Russell 1000 member Rebalance outlook locked
Going-concern doubt — flagged Jul 23, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Jul 23, 2026
Market Cap
$14.00B
Shares
797.75M

Analyst Estimates

Compare analyst forecasts for Summit Therapeutics Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1599298 CUSIP 86627T108 13F (30d) 93 filings 93 filers Visit website Investor relations